CD8A and neoplasm: Indeed, the administration of FTY720 (blocks lymphocyte egress from LNs) led to a significant reduction in the recruitment of tumour-infiltrating CD8+ T cells further supporting mature TA-HEVs in actively recruiting T cells from the periphery [12].